John J Crowley
CIK 1587972 · Chief Financial Officer · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.58M
Companies
3
Total Filings
21
Lifetime Open-Market Net
-$185.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Financial Officer | 0 | $40.50 | $0 | $0 | 4 | 2026-06-24 |
| Fusion Pharmaceuticals Inc. (FUSN) Delisted | Chief Financial Officer | 0 | $21.55 | $0 | $110.5K | 7 | 2024-06-04 |
| CRL | SVP, Chief Accounting Officer | 5,599 | $282.00 | $1.58M | -$296.4K | 10 | 2016-10-04 |
Recent Filings · Page 2 of 3
21 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-30 | Fusion Pharmaceuticals Inc. (FUSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-04 | CRL | Tax (F) | −284 | -$23.7K | EDGAR |
| 2016-05-25 | CRL | Mixed | — | -$61.7K | EDGAR |
| 2016-03-01 | CRL | Mixed | +949 | -$10.6K | EDGAR |
| 2015-10-02 | CRL | Tax (F) | −285 | -$18.1K | EDGAR |
| 2015-03-06 | CRL | Mixed | — | -$15.6K | EDGAR |
| 2015-03-02 | CRL | Mixed | +612 | -$17.4K | EDGAR |
| 2014-11-05 | CRL | Mixed | — | -$17.4K | EDGAR |
| 2014-10-02 | CRL | Tax (F) | −286 | -$17.1K | EDGAR |
| 2014-03-04 | CRL | Grant (A) | +1,393 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.